A comprehensive review by an international consortium of scientists has raised serious concerns about the safety profile of mRNA COVID-19 vaccines.
Review articles are summaries of current research on a particular topic. They are also sometimes called literature reviews or secondary sources.
The review “N1-methyl-pseudouridine (m1Ψ): friend or foe of cancer?” published in Science Direct, delves into the potential implications of a vaccine ingredient, N1-methyl-pseudouridine (m1Ψ), which could play a role in immune suppression and cancer proliferation.
m1Ψ was incorporated into Pfizer-BioNTech’s COVID-19 mRNA vaccine to improve its efficacy.
This component was introduced into the mRNA vaccine as a means to produce a significant amount of modified SARS-CoV-2 spike mRNA through in vitro transcription (IVT). This modification was crucial in the rapid development and deployment of the vaccine during the height of the pandemic.
However, the review article questions the long-term impacts of this modification, particularly regarding the interaction of the vaccine with the body’s immune response and potential carcinogenic effects.
According to the review abstract, evidence suggests that while mRNA vaccines may have been “effective” in reducing severe disease outcomes, they may not provide sterilizing immunity, leaving individuals susceptible to recurrent infections.
More critically, the review highlights that the inclusion of m1Ψ in mRNA vaccines appears to inhibit key immunological pathways, impairing the body’s early interferon signaling.
Interferon is a natural substance that helps the body’s immune system fight infections and other diseases, such as cancer.
This immunosuppression, intended to ensure efficient synthesis of the spike protein and minimize immune activation, may inadvertently foster an environment conducive to cancer development and metastasis.
In contrast, mRNA vaccines without this modification showed the opposite effect.
“Based on this compelling evidence, we suggest that future clinical trials for cancers or infectious diseases should not use mRNA vaccines with 100% m1Ψ modification, but rather those with the lowest percentage of m1Ψ modification to avoid immune suppression,” they the researchers said.
BREAKING: A new study published by an international team of researchers confirms what some medical experts have suspected for 18 months:
COVID mRNA injections containing N1-methyl-pseudouridine SUPPRESS the immune system and STIMULATE cancer growth! https://t.co/CwKD14ZQc9 pic.twitter.com/W530bWiVcK— Ned Nikolov, Ph.D. (@NikolovScience) April 16, 2024
The Gateway Pundit previously reported that a recent report released by the American Cancer Society predicted that new cancer cases are expected to reach a new high in 2024. Over 2 million new cancer cases are expected.
Cancer incidence is increasing for six of the most common cancers: breast, prostate, endometrium, pancreas, kidney and melanoma.
In 2022, Ohio attorney Thomas Renz presented DOD medical billing data from the Defense Medical Epidemiology Database (DMED) that revealed the disturbing truth about what is happening to the health of our service members since the launch of the Vaccine.
According to Renz, there has been an astronomical increase in several serious illnesses and ailment diagnoses in the US military after the rushed COVID-19 vaccine rollout – most of them – cancer, which saw a 3-fold increase.
“We have substantial data showing that we’ve seen, for example, a 300% increase in miscarriages over the five-year average, almost. We saw an almost 300% increase in cancer compared to the five-year average,” he said during the roundtable in Washington, D.C., hosted by Senator Ron Johnson (R-WI).
THE Wall Street Journal reports that doctors are baffled by the sudden rise in cancer among young people.
The newspaper writes:
“Cancer is affecting more and more young people in the United States and around the world, baffling doctors. Diagnosis rates in the United States increased in 2019 to 107.8 cases per 100,000 people under age 50, up 12.8% from 95.6 in 2000, federal data show. A study conducted last year in BMJ Oncology reported a sharp global increase in cancers in people under 50, with the highest rates in North America, Australia and Western Europe.”
The word “vaccine” appears nowhere in the article. He continues without thinking that doctors “are racing to understand what makes them sick and how to identify young people at high risk. They suspect that changes in the way we live – less physical activity, more ultra-processed foods, new toxins – have increased the risk for younger generations.”
Maybe doctors should start focusing on the obvious.
Dr. Angus Dalgleish, a renowned oncologist practicing in the United Kingdom, recently wrote an open letter to the editor-in-chief of the medical journal The BMJ, urging the journal to “make valid informed consent for COVID vaccination a priority topic” because cancers and other diseases are rapidly progressing among “enhanced” people.
“Reports of innate immune suppression following mRNA for several weeks would be appropriate, as all of these patients to date have melanoma or B-cell tumors, which are very susceptible to immune control – and this is before reports of suppressor gene suppression by mRNA in laboratory experiments,” wrote Dr. Dalgleish.
The Gateway Pundit also reported the case of Dr. Michael Goldman, a pro-COVID Belgian vaccine doctor and professor at the Free University of Brussels, Belgium, specializing in internal medicine and immunology, where he suggested that the mRNA vaccine could make lymphoma cancer worse.
On September 22, 2021, Goldman looked forward to receiving the booster dose of the mRNA vaccine. As he was about to undergo chemotherapy that would leave him immunocompromised, he worried that he was not protected enough from Covid-19.
Within a few days of the boost, Goldman’s cancer symptoms – including night sweats, tiredness and swollen lymph nodes – worsened.
“Such cancer progression within three weeks is surprising given what we know about the natural course of lymphoma, and Goldman needed steroids as soon as possible. Goldman began to suspect that the booster vaccine had somehow worsened his lymphoma, making his chances of survival for more than five years only 30%,” Newsbreak reported.
The news outlet added: “Before receiving the booster, the lymphoma was limited only to Goldman’s left armpit and neck. Coincidentally, Goldman received the first and second doses of the mRNA vaccine on his left arm. But Goldman received the recall on his right arm, and lymphoma began to appear in that arm.
Newsbreak author Shin Jie Yong, an MSC biology student, reported what he learned from a professor who told him about seven patients with stage IV tumors who were well-controlled for nearly five years but suddenly progressed after receiving the Covid-19 vaccination.
Pro-vaccine advocate Michael Goldman, then 66, was challenged on whether or not to report the life-threatening adverse event he experienced after receiving a vaccine, according to Shin. Goldman and his colleagues finally decided to publish their results.
The case report suggests that vaccination with the Pfizer mRNA vaccine could induce rapid progression of angioimmunoblastic T-cell lymphoma (AITL), a rare and highly aggressive cancer that affects the lymphatic system. It is a type of non-Hodgkin lymphoma (NHL) that occurs when T cells, or white blood cells that fight infections, become cancerous and abnormal.
“To the best of our knowledge, this is the first observation to suggest that administration of a SARS-CoV-2 vaccine could induce the progression of AITL. Several arguments support this possibility. First, the dramatic speed and extent of progression manifested on two 18F-FDG PET-CTs performed 22 days apart. Such a rapid evolution would be completely unexpected in the natural course of the disease. Since mRNA vaccination is known to induce enlargement and hypermetabolic activity of draining lymph nodes, it is reasonable to postulate that it was the trigger for the observed changes,” the experts said.